Skip to main content
Conferences and Meetings 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II

Short name: updated-114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II-2025 Annual Meeting Poster Bundle Erythroid Development & Iron Metabolism
Course start date: 02/05/2026

Sections

General
0 activities

Hibiscus 2 Trial in Progress A global Phase 3 randomized double blind placebo controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease
A randomized double blind placebo controlled trial of a novel BTK inhibitor rilzabrutinib in patients with sickle cell disease SCD aged 10–65 years LIBRA Study
Disparities in venous thromboembolism management in patients with sickle cell disease A nationwide inpatient sample study
Mortality in sickle cell disease A report from the grndad registry
Splenomegaly patterns and clinical impact in African children with sickle cell anemia on hydroxyurea treatment
Targeting inflammation in sickle cell disease Association of GLP 1 agonist use with improved survival and reduced sickle cell crisis and cardiopulmonary complications
Application and challenges of the sickle cell outcome grading system SCOGS for classifying acute chest syndrome severity
Explainable AI based prediction of chronic kidney disease as a long term outcome of sickle cell disease in a large multi site observational data cohort
Availability of blood products and transfusion practices in sub saharan Africa for the management of patients with sickle cell disease A survey in 16 countries
Raising hemoglobin level with erythropoietin improves cerebral but not muscle tissue oxygenation in patients with sickle cell disease
Correlation between outpatient opioid dosage and hospital visits in sickle cell disease patients
Systematic intensification of red cell exchange with hydroxyurea decreased the transfusion burden in patients with sickle cell disease A single center retrospective cohort study
Pharmacokinetic PK guided vs weight based dosing of hydroxyurea for tanzanian children with sickle cell anemia
Subclinical neurovascular injury and cognitive outcomes in adults with sickle cell disease Prevalence and imaging correlates
Combined nutrition education and vocational training for caregivers of children with sickle cell anemia and severe malnutrition A feasibility study
Lived experience of pregnant patients with sickle cell disease A qualitative study
Subtotal versus total splenectomy in children with sickle cell disease Clinical outcomes and splenic function assessed by pocked red blood cell count
Bridging the gap Global caregiver perspectives on awareness motivators and barriers to clinical trial participation in sickle cell disease
Applying the bedside SaO2 FiO2 ratio to adolescents with acute chest syndrome to triage ICU transfer
Understanding the impact of chronic red blood cell transfusion on day to day functioning in sickle cell disease SCD A mixed methods study of pediatric and adult experience
Real world experience of voxelotor treatment in patients with sickle cell disease
Venous thromboembolism and bleeding rates in pregnant and postpartum patients with sickle cell disease
Cardiopulmonary complications during pregnancy as a risk factor for cesarean delivery in a two center sickle cell disease pregnancy cohort
Development of the sickle cell outcome grading system SCOGS a novel classification system for sickle cell disease severity
Improvement in kidney function after 12 months of voxelotor in sickle cell disease patients
Does stroke or silent infarct affect quality of life in adults with sickle cell disease A multi centre study
Impact of the duffy null phenotype on hydroxyurea dosing and clinical outcomes in children with sickle cell disease

Vimeo Vimeo
27